معلومات عن هذه الحلقة
Dr Nimer meets with ecancertv at ASCO 2016 to discuss haematological malignancies.
الإنجليزية
الولايات المتحدة
النص 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
البحث في الحلقات الماضية
البحث في الحلقات السابقة من 2016 ASCO Annual Meeting.
حلقات أخرى في هذا البودكاست
Dr Van Den Bent presents at ASCO 2016 about the phase III trial, which showed that patients with anaplastic glioma without 1p/19q co-deletion benefit from adjuvant chemotherapy, according to early results from a European phase III trial.
Prof Schilsky talks to ecancertv at ASCO 2016 about the latest in precision medicine.
Dr Choueiri speaks with ecancertv at ASCO 2016 about results from METEOR, a randomised phase III trial of cabozantinib for patients with advanced renal cell carcinoma (RCC), compared to everolimus.
Cabozantinib displayed a significant impact on previously treated patients, improving median overall…
Professor Menon speaks with ecancertv at ASCO 2016 about screening strategies to detect early stage ovarian cancer.
Ovarian cancer was responsible for over 14,000 deaths in the US last year, but is often not diagnosed in stage I-III.
With regular screening, such as annual ultrasound and multimoda…
Dr Pal talks to ecancertv at ASCO 2016 about a study that looked at the uptake of BRCA genetic tests among young cancer survivors aged 50 or under. In particular, they compared black, hispanic, and non-hispanic white women.
The study found that there were large disparities, with significantly fewe…
إخلاء المسؤولية: البودكاست والأعمال الفنية المضمنة في هذه الصفحة مأخوذة من ecancer.org، وهي مملوكة لمالكها وليست تابعة لشركة Listen Notes, Inc أو معتمدة منها.
تعديل
شكراً على مساعدتنا في الحفاظ على قاعدة بيانات البودكاست مُحدَّثة.
